{"id":"cggv:dd041c1e-57d9-452d-ba92-f0bb297f067ev1.0","type":"EvidenceStrengthAssertion","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"cggv:dd041c1e-57d9-452d-ba92-f0bb297f067e_contrib","agent":"http://dataexchange.clinicalgenome.org/agent/10005","date":"2024-01-16T20:00:00.000Z","role":"Approver"},{"id":"cggv:dd041c1e-57d9-452d-ba92-f0bb297f067e_publish_contrib","agent":"http://dataexchange.clinicalgenome.org/agent/10005","date":"2024-03-29T21:07:34.003Z","role":"Publisher"}],"curationReasons":{"id":"cg:NewCuration"},"evidence":[{"id":"cggv:dd041c1e-57d9-452d-ba92-f0bb297f067e_experimental_evidence_line","type":"EvidenceLine","specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":0},{"id":"cggv:dd041c1e-57d9-452d-ba92-f0bb297f067e_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"cggv:840a07aa-54b5-4271-be0e-445961c79abf_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:840a07aa-54b5-4271-be0e-445961c79abf","type":"Proband","allele":{"id":"cggv:dcc02571-d8b9-4817-b7fc-68eb0962bc87","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015178.3(RHOBTB2):c.192+4A>C","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA4672385"}},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0000750","obo:HP_0000252","obo:HP_0100716","obo:HP_0012758","obo:HP_0001250"],"sex":"Male","variant":{"id":"cggv:c0cf63a4-2d08-4df1-9e56-a5269a030e2f_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:dcc02571-d8b9-4817-b7fc-68eb0962bc87"},"alleleOrigin":{"id":"obo:GENO_0000888"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Homozygous"},"dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/37165955","type":"dc:BibliographicResource","dc:abstract":"Missense variants clustering in the BTB domain region of RHOBTB2 cause a developmental and epileptic encephalopathy with early-onset seizures and severe intellectual disability.","dc:creator":"Langhammer F","dc:date":"2023","dc:title":"Genotype-phenotype correlations in RHOBTB2-associated neurodevelopmental disorders."}},"rdfs:label":"Langhammer F1_24"},{"id":"cggv:c0cf63a4-2d08-4df1-9e56-a5269a030e2f","type":"obo:SEPIO_0004097","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"cggv:c0cf63a4-2d08-4df1-9e56-a5269a030e2f_variant_evidence_item"},{"id":"cggv:c0cf63a4-2d08-4df1-9e56-a5269a030e2f_function_evidence_item","type":"VariantFunctionalImpactEvidence","functionalDataSupport":"Yes","dc:description":"Aberrant splicing was confirmed by an in vitro splice assay."}],"strengthScore":0.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:b4f3ca82-4c2f-4905-a043-3829326592c6_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:b4f3ca82-4c2f-4905-a043-3829326592c6","type":"Proband","allele":{"id":"cggv:d17fd05a-2095-4225-aa55-ff1b3326a5e6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015178.3(RHOBTB2):c.1932dup (p.Lys645GlnfsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2695201716"}},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0000752","obo:HP_0001249","obo:HP_0000750","obo:HP_0001276","obo:HP_0001250"],"sex":"Male","variant":{"id":"cggv:440e824d-54a3-4338-9276-b6141ca796cb_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:d17fd05a-2095-4225-aa55-ff1b3326a5e6"},"alleleOrigin":{"id":"obo:GENO_0000888"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/37165955"},"rdfs:label":"Langhammer F5_31"},{"id":"cggv:440e824d-54a3-4338-9276-b6141ca796cb","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:440e824d-54a3-4338-9276-b6141ca796cb_variant_evidence_item"}],"strengthScore":1,"dc:description":"The Epilepsy GCEP generally does not score homozygous predicted/proven null variants above 2 points per proband."}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:dd041c1e-57d9-452d-ba92-f0bb297f067e_ar_el","type":"EvidenceLine","specifiedBy":"GeneValidityOverallAutosomalRecessiveVariantEvidenceCriteria","strengthScore":12},{"id":"cggv:e46765a0-1fb8-4d5a-bb1b-311c16f88a92_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:e46765a0-1fb8-4d5a-bb1b-311c16f88a92","type":"Proband","allele":{"id":"cggv:8ceb9019-159a-45be-b591-c32f8fdce6fe","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015178.3(RHOBTB2):c.1942C>T (p.Arg648Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA4672829"}},"detectionMethod":"Method not specified","firstTestingMethod":"Other","phenotypes":["obo:HP_0001249","obo:HP_0001250"],"previousTesting":false,"sex":"Male","variant":{"id":"cggv:4c9337f1-bb3f-48ee-8cc8-b89fce864acc_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:8ceb9019-159a-45be-b591-c32f8fdce6fe"},"alleleOrigin":{"id":"obo:GENO_0000888"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/37165955"},"rdfs:label":"Langhammer F6_32"},{"id":"cggv:4c9337f1-bb3f-48ee-8cc8-b89fce864acc","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:4c9337f1-bb3f-48ee-8cc8-b89fce864acc_variant_evidence_item"}],"strengthScore":1,"dc:description":"The Epilepsy GCEP generally does not score homozygous predicted/proven null variants above 2 points per proband."}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:159dc2dd-759f-43d5-9ba7-55a3207a18e8_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:159dc2dd-759f-43d5-9ba7-55a3207a18e8","type":"Proband","allele":{"id":"cggv:11ee265f-1410-49af-8212-119d068d0039","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015178.3(RHOBTB2):c.1560del (p.Ser521AlafsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2695201715"}},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001250","obo:HP_0008936","obo:HP_0002509","obo:HP_0000750","obo:HP_0012758"],"previousTesting":false,"sex":"Male","variant":{"id":"cggv:271c0ea7-5d80-4fa8-a375-cffdc441cf65_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:11ee265f-1410-49af-8212-119d068d0039"},"alleleOrigin":{"id":"obo:GENO_0000888"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/37165955"},"rdfs:label":"Langhammer F4_30"},{"id":"cggv:271c0ea7-5d80-4fa8-a375-cffdc441cf65","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:271c0ea7-5d80-4fa8-a375-cffdc441cf65_variant_evidence_item"}],"strengthScore":1,"dc:description":"The Epilepsy GCEP generally does not score homozygous predicted/proven null variants above 2 points per proband."}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:7d903de8-ce56-47d0-bc06-58114229e918_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:7d903de8-ce56-47d0-bc06-58114229e918","type":"Proband","allele":{"id":"cggv:210a2596-26dd-4263-b238-855cbdf0008a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015178.3(RHOBTB2):c.2034C>G (p.Tyr678Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA370577154"}},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0000286","obo:HP_0001250","obo:HP_0012758"],"previousTesting":false,"sex":"Male","variant":{"id":"cggv:d7eaf90a-9e5a-4c48-8809-8acb46c06ea2_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:210a2596-26dd-4263-b238-855cbdf0008a"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/37165955"},"rdfs:label":"Langhammer F8_35"},{"id":"cggv:d7eaf90a-9e5a-4c48-8809-8acb46c06ea2","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:d7eaf90a-9e5a-4c48-8809-8acb46c06ea2_variant_evidence_item"}],"strengthScore":1,"dc:description":"The Epilepsy GCEP generally does not score homozygous predicted/proven null variants above 2 points per proband."}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:3b25834e-2ca4-4a81-aae9-f9ccc40fe85f_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:3b25834e-2ca4-4a81-aae9-f9ccc40fe85f","type":"Proband","allele":[{"id":"cggv:52630238-ed3d-4358-9bbe-af3f26dbc86f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015178.3(RHOBTB2):c.1502-1G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA370569813"}},{"id":"cggv:1243cec7-ed7b-4b9a-99bc-29c01287dcde","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015178.3(RHOBTB2):c.248G>A (p.Trp83Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA370560453"}}],"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001251","obo:HP_0001249","obo:HP_0001250"],"previousTesting":false,"sex":"Female","variant":[{"id":"cggv:1ebac7bf-88d9-4a14-ae6c-51bd51dfbdc9_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:52630238-ed3d-4358-9bbe-af3f26dbc86f"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/37165955"},{"id":"cggv:660e5695-b401-4f35-82fa-8c818758a970_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:1243cec7-ed7b-4b9a-99bc-29c01287dcde"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:TwoVariantsInTrans"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/37165955"}],"rdfs:label":"Langhammer F9_36"},{"id":"cggv:660e5695-b401-4f35-82fa-8c818758a970","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:660e5695-b401-4f35-82fa-8c818758a970_variant_evidence_item"}],"strengthScore":1.5},{"id":"cggv:1ebac7bf-88d9-4a14-ae6c-51bd51dfbdc9","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:1ebac7bf-88d9-4a14-ae6c-51bd51dfbdc9_variant_evidence_item"},{"id":"cggv:1ebac7bf-88d9-4a14-ae6c-51bd51dfbdc9_function_evidence_item","type":"VariantFunctionalImpactEvidence","functionalDataSupport":"No","dc:description":"Aberrant splicing was confirmed by an in vitro splice assay "}],"strengthScore":1.5}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:ecc4a250-2ac1-4161-abfa-12b372c0e7d0_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:ecc4a250-2ac1-4161-abfa-12b372c0e7d0","type":"Proband","allele":{"id":"cggv:b534711b-223b-4dd7-ad53-a6f0e7ab6b2d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015178.3(RHOBTB2):c.469C>T (p.Arg157Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA370561779"}},"detectionMethod":"Method not specified","firstTestingMethod":"Other","phenotypes":["obo:HP_0000750","obo:HP_0001251","obo:HP_0001250","obo:HP_0001252"],"sex":"Female","variant":{"id":"cggv:7e4525b9-1d09-4610-a504-b7590eff23b5_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:b534711b-223b-4dd7-ad53-a6f0e7ab6b2d"},"alleleOrigin":{"id":"obo:GENO_0000888"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/37165955"},"rdfs:label":"Langhammer F3_29"},{"id":"cggv:7e4525b9-1d09-4610-a504-b7590eff23b5","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:7e4525b9-1d09-4610-a504-b7590eff23b5_variant_evidence_item"}],"strengthScore":1,"dc:description":"The Epilepsy GCEP generally does not score homozygous predicted/proven null variants above 2 points per proband."}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:69dbf071-6572-4471-8ce4-aaf90334a79c_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:69dbf071-6572-4471-8ce4-aaf90334a79c","type":"Proband","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":6,"allele":{"id":"cggv:37a61830-6438-4791-80db-09927cce03b0","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015178.3(RHOBTB2):c.394C>T (p.Arg132Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA370561252"}},"firstTestingMethod":"Whole genome shotgun sequencing","phenotypes":["obo:HP_0002317","obo:HP_0001263"],"previousTesting":false,"sex":"Female","variant":{"id":"cggv:4a9fdd93-8260-41a0-87a0-6f3b28ceb2c0_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:37a61830-6438-4791-80db-09927cce03b0"},"alleleOrigin":{"id":"obo:GENO_0000888"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"},"dc:source":{"id":"https://pubmed.ncbi.nlm.nih.gov/33456446","type":"dc:BibliographicResource","dc:abstract":"There is a growing interest in standardizing gene-disease associations for the purpose of facilitating the proper classification of variants in the context of Mendelian diseases. One key line of evidence is the independent observation of pathogenic variants in unrelated individuals with similar phenotypes. Here, we expand on our previous effort to exploit the power of autozygosity to produce homozygous pathogenic variants that are otherwise very difficult to encounter in the homozygous state due to their rarity. The identification of such variants in genes with only tentative associations to Mendelian diseases can add to the existing evidence when observed in the context of compatible phenotypes. In this study, we report 20 homozygous variants in 18 genes (","dc:creator":"Maddirevula S","dc:date":"2020","dc:title":"Exploiting the Autozygome to Support Previously Published Mendelian Gene-Disease Associations: An Update."}},"rdfs:label":"20DG0038"},{"id":"cggv:4a9fdd93-8260-41a0-87a0-6f3b28ceb2c0","type":"obo:SEPIO_0004097","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"cggv:4a9fdd93-8260-41a0-87a0-6f3b28ceb2c0_variant_evidence_item"}],"strengthScore":1,"dc:description":"The Epilepsy GCEP generally does not score homozygous predicted/proven null variants above 2 points per proband."}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"},{"id":"cggv:accd150f-332e-47e5-a1d6-88543d45f47c_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"cggv:accd150f-332e-47e5-a1d6-88543d45f47c","type":"Proband","allele":{"id":"cggv:97ea3ee2-9a76-42f6-8fd2-0f67bbdb5733","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015178.3(RHOBTB2):c.1966+1G>C","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA370576177"}},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001256","obo:HP_0000750","obo:HP_0001250"],"previousTesting":false,"sex":"Female","variant":{"id":"cggv:715d0a23-0b13-4ed9-a991-7c3162bfb1fe_variant_evidence_item","type":"obo:SEPIO_0004116","allele":{"id":"cggv:97ea3ee2-9a76-42f6-8fd2-0f67bbdb5733"},"alleleOrigin":{"id":"obo:GENO_0000888"},"zygosity":{"id":"cg:Homozygous"},"dc:source":"https://pubmed.ncbi.nlm.nih.gov/37165955"},"rdfs:label":"Langhammer F7_34"},{"id":"cggv:715d0a23-0b13-4ed9-a991-7c3162bfb1fe","type":"obo:SEPIO_0004097","calculatedScore":2,"direction":"Supports","evidence":[{"id":"cggv:715d0a23-0b13-4ed9-a991-7c3162bfb1fe_variant_evidence_item"},{"id":"cggv:715d0a23-0b13-4ed9-a991-7c3162bfb1fe_function_evidence_item","type":"VariantFunctionalImpactEvidence","functionalDataSupport":"Yes","dc:description":"Aberrant splicing was confirmed by an in vitro splice assay"}],"strengthScore":1,"dc:description":"The Epilepsy GCEP generally does not score homozygous predicted/proven null variants above 2 points per proband."}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria"}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":7993,"specifiedBy":"GeneValidityCriteria10","strengthScore":12,"subject":{"id":"cggv:348e0031-0ea7-4d77-a16b-dd30d0ca6542","type":"GeneValidityProposition","disease":"obo:MONDO_0100038","gene":"hgnc:18756","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","dc:description":"*RHOBTB2* was first reported in relation to autosomal recessive complex neurodevelopmental disorder in 2020 (Maddirevula et al., PMID: 33456446). Phenotypic features in individuals with biallelic *RHOBTB2* variants include intellectual disability, hypotonia and/or hypertonia, microcephaly, seizures, and movement disorders. Reported seizure types include absence, febrile, and generalized tonic clonic seizures with onset typically in neonatal period and infancy (PMID: 37165955). Of note, there have also been many reported cases of individuals with *de novo* heterozygous missense variants in *RHOBTB2* and complex neurodevelopmental disorder. Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found differences in inheritance pattern and molecular mechanism, with the autosomal recessive (AR) presentation being primarily loss of function variants and the autosomal dominant (AD) presentation being primarily missense variants. Therefore, the curations for AD and AR complex neurodevelopmental disorder have been split, and cases with AD *RHOBTB2* variants have been curated separately by the Epilepsy GCEP.\n \nEight homozygous variants reported in eight probands from 2 publications are included in this curation (PMIDs: 33456446, 37165955). Additionally, one individual with compound heterozygous nonsense and canonical splice site variants has also been reported (PMID: 37165955). The mechanism of pathogenicity appears to be loss of function, as reported variants are nonsense, frameshift and splice site in probands with biallelic variants (PMID: 37165955). There was no experimental evidence utilized for this curation.\n\nIn summary, there is definitive evidence supporting the relationship between *RHOBTB2* and AR complex neurodevelopmental disorder. This has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time. This classification was approved by the ClinGen Epilepsy GCEP on the meeting date January 16, 2024 (SOP Version 10).","dc:isVersionOf":{"id":"cggv:dd041c1e-57d9-452d-ba92-f0bb297f067e"},"@context":{"@vocab":"http://dataexchange.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"http://dataexchange.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"http://dataexchange.clinicalgenome.org/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"}}}